Fewer eye injections possible? new study tests Higher-Dose aflibercept for DME
NCT ID NCT06422507
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a higher dose (8 mg) of the drug aflibercept, given every 16 weeks, works as well as the standard dose (2 mg) given every 8 weeks for Chinese people with diabetic macular edema (DME), a diabetes-related eye condition that causes vision problems. 333 participants received either the high-dose or standard-dose injections into the eye. The main goal was to compare changes in vision after 48 weeks. If the higher dose works, it could mean fewer injections and less frequent doctor visits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- aflibercept (8 mg and 2 mg doses)
- What this could lead to
- If successful, this could mean fewer eye injections for people with diabetic macular edema, making treatment easier and less burdensome.
- What could go wrong
- This is a completed Phase 3 trial, but results are not yet published. The higher dose may not be as effective or safe as the lower dose, and findings in Chinese participants may not apply to other populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated hospital of Nantong university
Nantong, Jiangsu, 226006, China
-
Aier Eye Hospital (LIAONING)
Shenyang, Liaoning, China
-
Beijing Aier Intech Eye Hospital
Beijing, 100000, China
-
Beijing Friendship Hospital, Capital Medical University
Beijing, 100050, China
-
Beijing Hospital
Beijing, Beijing Municipality, 100730, China
-
Capital Medical University (CMU) - Beijing Tongren Hospital
Beijing, 100062, China
-
Central South University - The Second Xiangya Hospital
Changsha, 410007, China
-
Chengdu Aier Ophthalmology Hospital
Chengdu, 610041, China
-
Chengdu University of Traditional Chinese Medicine - Teaching Hospital (Sichuan Province Traditional Chinese Medicine Hospital)
Chengdu, 610072, China
-
Eye & Ent Hospital of Fudan University
Shanghai, 200126, China
-
Eye Hospital of Wenzhou Medical University
Wenzhou, 325027, China
-
Eye hospital of Shandong First Medical University
Jinan, 250299, China
-
Grantham Hospital
Hong Kong, Hong Kong SAR, 00000, Hong Kong
-
Guangdong Provincial Hospital of TCM
Guangzhou, Guangdong, 510120, China
-
Guangzhou Aier Ophthalmology Hospital
Guangzhou, 510288, China
-
Guangzhou First People Hospital
Guangzhou, Guangdong, 510180, China
-
Hebei eye hospital
Hebei, 050010, China
-
Henan Provincial Eye Hospital
Henan, 450008, China
-
Jinan Second People's Hospital
Jinan, 250021, China
-
Joint Shantou International Eye Center (JSIEC)Shantou University & the Chinese University of Hong Kong
Shantou, 515041, China
-
Lanzhou University Second Hospital
Lanzhou, Gansu, 730030, China
-
Luoyang Third People's Hospital
Luoyang, Henan, 471002, China
-
Nanjing First Hospital
Nanjing, Jiangsu, 210006, China
-
People's Hospital of Ningxia Hui Autonomous Region - Opthalmology
Ningxia, 750002, China
-
Renmin Hosp., Wuhan Univ.
Wuhan, Hubei, 430040, China
-
Shandong University of Traditional Chinese Medicine Affiliated Ophthalmology Hospital
Shandong, 250299, China
-
Shanghai General Hospital
Shanghai, 200080, China
-
Shanghai Jiao Tong University School of Medicine (SJTUSM) - XinHua Hospital
Shanghai, 200092, China
-
Shanghai eye disease prevention and control center
Shanghai, 200041, China
-
Shanxi Bethune Hospital
Taiyuan, Shanxi, 030032, China
-
Shanxi Eye Hospital
Shanxi, 030002, China
-
Shenyang He Eye Specialist Hospital
Shenyang, 110034, China
-
Shijiazhuang People's Hospital
Shijiazhuang, 050011, China
-
Sichuan University West China Hospital
Chengdu, Sichuan, MISSING, China
-
Taizhou Hospital of Zhejiang Province
Taizhou, Zhejiang, 317099, China
-
The First Affiliated Hospital of Chongqing Medical Universit
Chongqing, 400042, China
-
The First Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, 150001, China
-
The First Affiliated Hospital of NanChang University
Nanchang, Jiangxi, 330006, China
-
The First Hospital of Jilin University
Changchun, Jilin, 130061, China
-
The Fourth People's Hospital of Shenyang
Shenyang, 110082, China
-
The People's Hospital of Guangxi Zhuang Autonomous Region
Nanning, Guangxi, 530021, China
-
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330200, China
-
The Second Hospital of Anhui medical university
Hefei, Anhui, 230601, China
-
The Second Hospital of Jilin University
Changchun, Jilin, 130000, China
-
Tianjin Medical University Eye Hospital
Tianjin, 300384, China
-
Tseung Kwan O Hospital
Tseung Kwan O, New Territories, 00000, Hong Kong
-
Weifang Ophthalmology Hospital
Shandong, 261041, China
-
Xi'an People's Hospital (Xi'an Fourth Hospital)
Xi'an, 710005, China
-
Xianyang First People's Hospital
Xianyang, 712099, China
-
Zhejiang University School of Medicine - The Second Affiliated Hospital
Hangzhou, 310003, China
-
Zhengzhou Second People's Hospital
Erqi, Zhengzhou, 450015, China
-
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, 510280, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new eye injection preserve vision in south asians with diabetes?
- Could a biosimilar eye injection offer a new way to treat diabetic macular edema?
- Can a steroid implant boost the effect of standard eye injections for hard-to-treat diabetic macular edema?
- Eye injection aims to tame leading causes of blindness
- New eye drug aims to restore vision in Diabetes-Related swelling
- New eye drug aims to restore vision in Diabetes-Related swelling